Your browser doesn't support javascript.
loading
Retracted: Molecular characterization of excipients' preferential interactions with therapeutic monoclonal antibodies.
Kim, Jehoon; Krebs, Mark R H; Trout, Bernhardt L.
Afiliación
  • Kim J; Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Krebs MRH; Protein Pharmaceutical Development, Biogen, Cambridge, MA, USA.
  • Trout BL; Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.
J Pharm Pharmacol ; 70(2): 289-304, 2018 Feb.
Article en En | MEDLINE | ID: mdl-28776673
ABSTRACT
Retraction Molecular characterization of excipients' preferential interactions with therapeutic monoclonal antibodies by Jehoon Kim, Mark R. H. Krebs and Bernhardt L. Trout The above article from the Journal of Pharmacy and Pharmacology, first published online on 4 August 2017 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the authors, the journal Editor-in-Chief, Professor David Jones, and John Wiley & Sons Ltd. The authors discovered that the analysis of simulations was faulty making the data incorrect. Reference Kim J et al. Molecular characterization of excipients' preferential interactions with therapeutic monoclonal antibodies. J Pharm Pharmacol 2017. https//doi.org/10.1111/jphp.12787.

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: J Pharm Pharmacol Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: J Pharm Pharmacol Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos